| 1.266 -0.040 (-3.06%) 10-16 17:35 |
|
| Open: | 1.280 |
| High: | 1.312 |
| Low: | 1.266 |
| Pre. close: | 1.306 |
| Volume: | 62,499 |
| Avg. volume: | 195,327 |
| MA (50): | 1.387 |
| MA (200): | 1.804 |
| Year high: | 2.700 |
| Year low: | 1.100 |
| Market cap: | 76(M) |
| EPS: | -0.207 |
| PE ratio: | -6.12 |
| SELL | BUY |
| HeikinAshi: | |
| Kaufmans AMA: | |
| Chandelier (20): | |
| MA (5): | |
| MA (50): | |
| MACD (26,12,9): | |
| Slow KDJ (14,3): | |
| RSI (14): | |
| CCI (20): |
Fri, 25 Sep 2026
CROSSJECT strengthens its governance for the industrial and commercial deployment phase - GlobeNewswire
Thu, 24 Sep 2026
CROSSJECT Reports Its First-Half 2026 Results and Presents a Significantly Strengthened Financial Structure - Yahoo Finance
Wed, 23 Sep 2026
CROSSJECT and BARDA align ZEPIZURE®’s Pediatric development plan with FDA including funding through 2030 - GlobeNewswire
Fri, 22 May 2026
CROSSJECT announces the successful completion of an equity - GlobeNewswire
Wed, 25 Mar 2026
CROSSJECT publishes its 2025 financial results and confirms - GlobeNewswire
Tue, 18 Mar 2025
CROSSJECT achieves key ZEPIZURE® manufacturing batch stability milestones - Yahoo Finance UK
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.